RMResMed Inc. RMD · NYSE
$238.97 -1.35% (-$3.27)
- Market cap
- $35.2B
- Enterprise value
- $34.5B
- P/E
- 23.1x
- Forward P/E
- 20.2x
- PEG
- 2.6x
- P/S
- 6.2x
- P/FCF
- 12.2x
- EV/EBITDA
- 16.1x
- ROIC
- 19.1%
- Gross margin
- 61.2%
- Net margin
- 26.9%
- Dividend yield
- 1.02%
- Payout ratio
- 23.4%
- Net debt/EBITDA
- -0.3x
- Beta
- 0.75
- Free float
- 99.1%
About the company
ResMed Inc. (RMD) is an American healthcare company specializing in the development and production of devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. With a broad portfolio of products, including CPAP machines and ventilators, ResMed is one of the leading players in the medical technology market. The company is known for its focus on innovation and technological advancement, enabling it to provide high-quality and effective treatment options. ResMed also focuses on patient and healthcare provider education to improve treatment outcomes and patient quality of life. ResMed Inc. (RMD) shares could be suitable for investors looking for opportunities in the medical technology sector with an emphasis on respiratory care and innovation.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael J. Farrell
Employees
11,370
Headquarters
San Diego
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number